Cite
HARVARD Citation
Hendrickx, R. et al. (n.d.). SAT0245 Azd9567: a novel oral selective glucocorticoid receptor modulator, demonstrated to have an improved therapeutic ratio compared to prednisolone in pre-clinical studies, is safe and well tolerated in first clinical study.. Annals of the rheumatic diseases. pp. 984-985. [Online].